(Q41415279)

English

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels

scientific article published on December 1988

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

1 reference

based on heuristic

inferred from title

author name string

G Bertelli

1

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

P Pronzato

2

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

D Amoroso

3

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

M P Cusimano

4

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

P F Conte

5

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

G Montagna

6

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

S Bertolini

7

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

R Rosso

8

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

language of work or name

0 references

publication date

1 December 1988

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

307-310

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3228593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen treatment of metastatic breast cancer and antithrombin III levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/3228593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thrombosis as a side effect of tamoxifen treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/3228593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III

1 reference

https://pubmed.ncbi.nlm.nih.gov/3228593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/3228593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen and thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/3228593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen and thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3228593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01811244

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41415279&oldid=2204525430"